Venture Partner at Samsara BioCapital, and former CSO and COO of Karus Therapeutics, brings deep scientific and industry experience to Mosaic’s Executive Leadership team Stephen will lead the ...
Privately-held UK oncology company Mosaic Therapeutics has announced the appointment of Stephen Shuttleworth as chief scientific officer (CSO). Dr Shuttleworth, who replaces the retiring Barry Davies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback